Lipid profile in 4 minutes. Impressing your coronary heart disease patients
Janssen, K.
MMW Fortschritte der Medizin 142(26-27): 39
2000
ISSN/ISBN: 1438-3276 PMID: 10929482 Document Number: 515205
Document emailed within 1 workday
Related Documents
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590Gulati, S.; Saxena, A. 2003: Study of lipid profile in children of patients with premature coronary artery disease Indian Pediatrics 40(6): 556-560
Souza, D.R.S.; Nakachima, L.; Biagioni, R.B.; Nakazone, M.A.; Pinhel, M.A.S.; Trindade, D.M.; Mafra, V.T.; Tácito, L.H.B.; Martin, J.F.V.; Pinheiro Júnior, S.; Brandão, A.C. 2007: Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease Brazilian Journal of Medical and Biological Research 40(2): 189-197
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Wichmann, T.; Freye, H.A.; Meyer, E.; Teichmann, W.; Schmerling, S. 1982: Lipid chemical parameters and incidence of genetically determined hyperlipoproteinemias in patients between 20 and 45 years of age with coronary heart disease Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(12): 379-383
Vrazić, H.; Lucijanić, T.; Sikić, J.; Spoljarić, I.R.; Polić, S.; Ljubicić, D.; Matić, K.; Bozin, T.ći.; Subjak, I.; Bergovec, M. 2012: The prevalence of diabetes mellitus and abnormal lipid status among Croatian hospitalized coronary heart disease patients Collegium Antropologicum 36(Suppl 1): 223-228
Nepomniashchikh, V.A.; Lomivorotov, V.V.; Deriagin, M.N.; Lomivorotov, V.N.; Kniaz'kova, L.G.; Efimov, A.A. 2009: Lipid peroxidation and cytochrome P-450-dependent metabolism of xenobiotics in patients with coronary heart disease and multiple organ failure Anesteziologiia i Reanimatologiia 2: 52-56
Gottsauner-Wolf, M.; Gwechenberger, M.; Mörtl, D.; Sochor, H.; Stockenhuber, F.; Probst, P. 1995: Change in the patient profile in coronary heart disease at the time of initial evaluation with coronary angiography between 1975 and 1989 Zeitschrift für Kardiologie 84(2): 81-85
Modi, R.; Kothiwale, V.A.; Patted, S.; Halkati, P.C. 2017: APO B/APO Ai Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population Journal of the Association of Physicians of India 65(12): 22-27
Lankin, V.Z.; Gerasimova, E.N.; Kasatkina, L.V.; Tikhaze, A.K.; Suchkova, S.N. 1979: Lipid peroxides and atherosclerosis. the enzymatic detoxication of lipid peroxides in the blood in ischemic heart disease due to coronary artery arteriosclerosis Kardiologiia 19(6): 71-76
Kalyuzhin, V.V.; Teplyakov, A.T.; Pushnikova, E.Y.; Bespalova, L.D.; Kalyuzhina, E.V.; Kolesnikov, R.N. 2013: Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome Terapevticheskii Arkhiv 85(5): 68-72
Vorster, H.H.; Venter, C.S. 1993: Why fibrinogen should be measured as part of the coronary heart disease risk profile South African Medical Journal 83(5): 309-310
Taylor, O.G.; Oyediran, O.A.; Bamgboye, A.E.; Afolabi, B.M.; Osuntokun, B.O. 1996: Profile of some risk factors for coronary heart disease in a developing country: Nigeria African Journal of Medicine and Medical Sciences 25(4): 341-346
Opherk, D.; Mäurer, W.; Mehmel, H.C.; Müller, J.H.; Zebe, H.; Kübler, W. 1976: Coronary circulation and myocardial O2 consumption in patients with coronary heart disease under isometric load and in maximal coronary dilatation Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1188-1190
Nogués, X.; Sentí, M.; Pedro-Botet, J.; Molina, L.; Serrat, R.; Pons, S.; Rubiés-Prat, J. 1992: Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors Medicina Clinica 98(5): 171-174
Carstens, V.; Haum, A.; Grond, M.; Behrenbeck, D.W. 1986: Incidence of coronary artery disease and necessity for coronary angiography in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 83-85
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Xu, J.M.; Cai, P.Y. 1986: A study on the relation between phlegm-stagnant type coronary heart disease and serum lipid levels Journal of Traditional Chinese Medicine 6(3): 183-186
Scola, R.; Opherk, D.; Nüssel, E.; Kübler, W. 1975: Multivariable analysis of risk factors for coronary disease in post-heart infarct patients and in patients with angiographically demonstrable coronary sclerosis Zeitschrift für Kardiologie Suppl 2: 127
Bubnova, M.G. 2004: Atorvastatin: lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease Kardiologiia 44(8): 96-104